Grant Contact - Sign Up Page  





BMS Acquisition Announcement

Celgene is now part of Bristol-Myers Squibb creating a leading biopharma company positioned to help address the needs of patients with serious diseases. From February 1, 2020, all new funding applications must be submitted through the Bristol-Myers Squibb Corporate Grants and Giving website. For Independent Medical Education (IME) and Scientific Advancement Grant (SAG) requests such as fellowships, investigator awards and closed/invite-only scientifically-based meetings, please refer to the Corporate Giving FAQ link below for more information.

•  https://www.bms.com/about-us/responsibility/corporate-giving.html

To submit an application for an independent medical education (IME) grant, please visit:  https://www.bms.com/about-us/responsibility/IME.html
To submit an application for a Scientific Advancement Grant (SAG), please visit:  https://bms.com/about-us/responsibility/corporate-giving.html

Please refer to the following for more information:

•  BMS Corporate Giving Guidelines:  https://www.bms.com/about-us/responsibility/corporate-giving/giving-guidelines.html
•  BMS Corporate Giving FAQs:   https://www.bms.com/about-us/responsibility/corporate-giving/corporate-giving-faqs.html
•  BMS-IME Integration Information:   https://www.celgene.com/research-development/celgene-medical-affairs/medical-affairs-grants/independent-medical-education-grants/

If you have already submitted an application through Celgene systems and have not received a decision, please do not submit a duplicate application. Bristol-Myers Squibb will review all pending applications, and will get back to you as soon as possible with a decision.

Many thanks for your continued patience during this transition period.


Otezla Divestiture Announcement

As a result of the acquisition of Celgene by Bristol-Myers Squibb, and the divestiture of Otezla® to Amgen, funding requests related to Otezla® (dermatology, rheumatology and Behcet’s Disease) are no longer being accepted on Celgene’s funding portal.

As of Thursday, November 21, 2019, Amgen will accept related funding requests as follows:

* Please fill all the required fields.
* Invalid Email Address
* Invalid Phone/Fax Number
* Federal Tax Id format should be xx-xxxxxxx


* Please Accept Terms and Conditions


* Please fill Federal Tax Id and Zip code
* Please fill Federal Tax Id
* Please fill Zip code


Requestor Account Information:



Organization Name *
Address Line 1 *
Address Line 2
City *
State/Province *
Zip/Postal Code *
Country *
Phone *
Fax
Federal Tax ID *
 
Requestor Provider Type *
Requestor Provider Type Other *
Requestor Level of Accreditation *
Profit or Non Profit Status *
Email Address *

Contact Information:



First Name *
Last Name *
Degree
Title *
Email Address *
Mobile Phone
Terms and Conditions
Please enter contact information as requested below, for the person who will serve as the PRIMARY contact for this request. Any information you provide here will be used only for the purpose of evaluating your submission, and to authenticate your identity (the "Purpose").

Celgene will never sell or lease your information. Celgene may provide and transfer your information to its affiliates (the "Celgene Group of Companies"), as well as to those suppliers that provide services to the organization, with the guarantees established by the current applicable legislation regarding the protection of your personal data. In this respect, it is expressly authorized that information of a personal nature may be transferred to other countries of the European Economic Area and beyond, including the United States, which have their own legislation regarding personal data processing. However, Celgene shall implement the adequate measures for the protection of personal data. For a list of affiliates of the Celgene Group of Companies, access this link.

By clicking "Sign Up" below, you acknowledge and understand the statement above and agree to the terms of Celgene's Privacy Policy.
I Accept Terms and Conditions *